Procoagulant phospholipid surface (PPL)

Procoagulant phospholipid surfaces are specialized membrane environments, primarily defined by the externalization of phosphatidylserine (PS), that appear on the outer leaflet of activated platelets and tissue factor (TF)-expressing cells during vascular injury or pathological states (Zwaal & Schroit, 1997). In quiescent cells, flippases maintain PS on the inner membrane leaflet, but activation or apoptosis triggers scramblases to expose these negatively charged lipids to the extracellular space (Heemskerk et al., 2002). This exposed surface acts as a critical catalytic scaffold for the assembly of the tenase and prothrombinase complexes, which involve vitamin K-dependent clotting factors (Factors VII, IX, X, and prothrombin) binding via their gamma-carboxyglutamic acid (Gla) domains (Mann et al., 1990). By concentrating these factors in close proximity, the phospholipid surface accelerates thrombin generation by several thousand-fold, making it a central driver of both physiological hemostasis and pathological thrombosis (Mackman, 2004). In oncology, the exposure of PS on tumor vascular endothelium and TF-expressing tumor cells contributes to a prothrombotic state and immunosuppression within the tumor microenvironment (Thorpe, 2010). Therapeutic agents targeting these surfaces, such as Diannexin or bavituximab, aim to mask the exposed phospholipids to prevent clot formation or to direct immune responses against tumor cells, offering a strategy that targets the site of coagulation rather than inhibiting the enzymes directly (Rand et al., 2004). Monitoring these surfaces is clinically relevant, with assays measuring procoagulant phospholipid activity (PPL) used as biomarkers for thrombotic risk (Exner et al., 2003). Safety concerns primarily involve the potential for bleeding and the theoretical risk of interfering with the normal clearance of apoptotic cells, which also rely on PS exposure for recognition by phagocytes (Ravichandran, 2011).

Other names

PhosphatidylserineAnionic phospholipid surfaceProcoagulant membraneActivated platelet surfaceTF-expressing cell surface

Binding to and masking exposed anionic phospholipids, particularly phosphatidylserine, to sterically hinder the assembly of vitamin K-dependent coagulation factor complexes (tenase and prothrombinase) on the cell surface (Rand et al., 2004; Thorpe, 2010).